Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification

Abstract

Both increase and decrease of cardiac inward rectifier current (I K1 ) are associated with severe cardiac arrhythmias. Flecainide, a widely used antiarrhythmic drug, exhibits ventricular proarrhythmic effects while effectively controlling ventricular arrhythmias associated with mutations in the gene encoding Kir2.1 channels that decrease I K1 (Andersen syndrome). Here we characterize the electrophysiological and molecular basis of the flecainide-induced increase of the current generated by Kir2.1 channels (I Kir2.1 ) and I K1 recorded in ventricular myocytes. Flecainide increases outward I Kir2.1 generated by homotetrameric Kir2.1 channels by decreasing their affinity for intracellular polyamines, which reduces the inward rectification of the current. Flecainide interacts with the HI loop of the cytoplasmic domain of the channel, Cys311 being critical for the effect. This explains why flecainide does not increase I Kir2.2 and I Kir2.3 , because Kir2.2 and Kir2.3 channels do not exhibit a Cys residue at the equivalent position. We further show that incubation with flecainide increases expression of functional Kir2.1 channels in the membrane, an effect also determined by Cys311. Indeed, flecainide pharmacologically rescues R67W, but not R218W, channel mutations found in Andersen syndrome patients. Moreover, our findings provide noteworthy clues about the structural determinants of the C terminus cytoplasmic domain of Kir2.1 channels involved in the control of gating and rectification.T he cardiac inwardly rectifying K + current (I K1 ) stabilizes resting membrane potential (RMP) close to the reversal potential of K + (E K ) and shapes the final repolarization phase of the action potential (AP) (1). Three inwardly rectifying channels (Kir2.1, Kir2.2, and Kir2.3) contribute to I K1 in the human heart assembled as homo-and/or heterotetramers (2). Experimental data suggest that in humans, Kir2.1 is the major isoform underlying ventricular I K1 , whereas its relative contribution to atrial I K1 seems to be lower (3). The strong inward rectification of Kir2.x channels, i.e., the preferential conduction of inward compared with outward current, depends on the binding of intracellular Mg 2+ and polyamines to the cytoplasmic pore and to the inner vestibule of the channel (4).Gain-and loss-of-function mutations in the gene that encodes Kir2.1 (KCNJ2) have been reported, and both the I K1 increase and decrease produced by these mutations are associated with severe ventricular arrhythmias (1). Furthermore, experimental data showed that as the amplitude of the outward component of the I K1 increases, the frequency of the fast and stable reentry of spiral waves (rotors) increases. Indeed, the importance of I K1 in the establishment of rotors and ventricular fibrillation dynamics has been shown (5).Flecainide is a class I antiarrhythmic drug that, besides its Na + channel-blocking properties, exhibits class III antiarrhythmic effects [i.e., prolongs AP duration (APD) and refractoriness] at the atrial but not at the ventricular le...

Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes

“…Several reports have concluded that both heteromeric and homomeric assembly of Kir2.x channels are the basis of native I K1 [16][17][18]. We have previously observed the effects of zacopride on cells co-transfected with heteromers of Kir2.1/Kir2.2, Kir2.2/Kir2.3, or Kir2.1/Kir2.3 [19]. Our results showed that zacopride did not induce an effect on the inward or outward components of the heteromeric channels, Kir2.1/Kir2.2, Kir2.2/Kir2.3, or Kir2.1/Kir2.3 ( Figures 3D-F, respectively).…”

Tbx20 controls the expression of the KCNH2 gene and of hERG channels

“…Currents were recorded using the whole-cell patch-clamp technique (15,17,18,30). Series resistance was compensated manually using the compensation unit of the Axopatch amplifier; ≥80% compensation was achieved.…”

“…HL-1 and Chinese hamster ovary cells were transiently transfected by using Lipofectamine 2000 and FuGENE X-tremeGENE, respectively, and cultured as described (15,17,18,30).…”

KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia

“…The mechanisms at play have not been fully elucidated in RYR2 related syndromes since in the RYR2 R4496C+/− transgenic mouse blockade of Ca 2+ transients and sparks was not determined not to be the antiarrhythmic mechanism, but rather flecainide sodium channel blockade which was the primary target for effective arrhythmia suppression(22). An alternative mechanism is related to the observation that flecainide, via a cysteine reside at position 311, has been shown to decrease Kir2.1 channel affinity for intracellular polyamine blockade, which functionally results in an increase in outward current(23). This, in essence, corrects the effect that the R67Q mutation induces and, thus, flecainide’s clinical action may also be directed on Kir2.1 channels.…”